Neurovia

BiotechnologySeries ASan Francisco, USneurovia-inc.com

Latest round

Series A

Last raised

Jul 2017

Total raised

$14M

Investors

4

About Neurovia

Established in 2013 and based in California, US, Neurovia, Inc. develops therapies to treat rare genetic neurological diseases.

Who invested in Neurovia

4 investors across 1 round

See all investors in Neurovia

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 20, 2017

    Amount

    $14M

    Investors

    Locked

Questions about Neurovia

Who invested in Neurovia?

Neurovia has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Neurovia raised?

Neurovia has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Neurovia last raise money?

Neurovia's most recent round on record is a Series A, in Jul 2017.

What does Neurovia do?

Established in 2013 and based in California, US, Neurovia, Inc.

Where is Neurovia headquartered?

Neurovia is headquartered in San Francisco, US.

Which VCs invest in companies like Neurovia?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neurovia's stage. Their profiles are linked below.

Raising like Neurovia? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.